Aqua Bio Technology ASA (OSL: ABTEC)

Market Cap	357.00M
Revenue (ttm)	13.82M
Net Income (ttm)	-1.50M
Shares Out	108.84M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	752,001
Average Volume	294,603
Open	2.800
Previous Close	2.800
Day's Range	2.700 - 3.410
52-Week Range	1.605 - 6.400
Beta	0.71
RSI	71.00
Earnings Date	Feb 12, 2025

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 4
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2022, Aqua Bio Technology ASA's revenue was 7.16 million, an increase of 262.49% compared to the previous year's 1.98 million. Losses were -18.74 million, -1.97% less than in 2021.